Harbour Investments’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.2K Sell
67
-20
-23% -$1.88K ﹤0.01% 3594
2026
Q1
$7.77K Buy
87
+17
+24% +$1.75K ﹤0.01% 3391
2025
Q4
$6.66K Hold
70
﹤0.01% 2909
2025
Q3
$6.9K Buy
70
+32
+84% +$3.42K ﹤0.01% 2854
2025
Q2
$4.05K Hold
38
﹤0.01% 2951
2025
Q1
$3.46K Hold
38
﹤0.01% 2945
2024
Q4
$4.33K Hold
38
﹤0.01% 2783
2024
Q3
$4.51K Hold
38
﹤0.01% 2663
2024
Q2
$3.05K Sell
38
-28
-42% -$2.56K ﹤0.01% 2686
2024
Q1
$6.09K Hold
66
﹤0.01% 2400
2023
Q4
$6.97K Sell
66
-134
-67% -$13.5K ﹤0.01% 2294
2023
Q3
$21.7K Hold
200
﹤0.01% 1710
2023
Q2
$21.6K Buy
200
+98
+96% +$11K ﹤0.01% 1737
2023
Q1
$12.7K Hold
102
﹤0.01% 1916
2022
Q4
$15.3K Sell
102
-40
-28% -$6.16K ﹤0.01% 1778
2022
Q3
$21K Hold
142
﹤0.01% 1614
2022
Q2
$21K Buy
+142
New +$21.7K ﹤0.01% 1614
2021
Q4
$37K Sell
142
-667
-82% -$183K ﹤0.01% 1389
2021
Q3
$221K Buy
809
+120
+17% +$38.1K 0.01% 975
2021
Q2
$154K Buy
689
+194
+39% +$36.6K ﹤0.01% 1175
2021
Q1
$54K Buy
+495
New +$52.6K ﹤0.01% 1651

Other funds holding BNTX

Harbour Investments's BNTX Position: Q2 2026 in Review

Harbour Investments reduced its BioNTech (BNTX) stake by 23% in Q2 2026, selling an estimated $1.88K and leaving 67 shares worth $6.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3594.

Harbour Investments first reported a position in BNTX in Q1 2021 and has held it in 21 quarters since. The position peaked at $221K in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Harbour Investments held 67 shares of BioNTech worth $6.2K as of Q2 2026.
  • Harbour Investments sold 20 BioNTech shares in Q2 2026, an estimated $1.88K.
  • BioNTech made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3594 holding.
  • Harbour Investments first reported a position in BioNTech in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's BioNTech position peaked at $221K in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.